Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Trends in Ecology & Evolution|April 1, 2017
Forests and Their Canopies: Achievements and Horizons in Canopy ScienceAkihiro Nakamura, Roger L Kitching, Min Cao, et al.
The American Journal of Surgical Pathology|January 21, 2014
Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patientsFanny Julia, Stephane Dalle, Gerard Duru, et al.
Scientific Reports|June 11, 2024
Late Holocene relative sea-level records from coral microatolls in SingaporeFangyi Tan, Benjamin P Horton, Lin Ke, et al.
Cancer Research|June 17, 2015
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell DeathEric A Lee, Leonard Angka, Sarah-Grace Rota, et al.
Papillomavirus Research (Amsterdam, Netherlands)|June 4, 2020
Multiple HPV infections among men who have sex with men engaged in anal cancer screening in Abuja, NigeriaRebecca G Nowak, Lisa M Schumaker, Nicholas P Ambulos, et al.
PLOS Global Public Health|July 2, 2025
Strengthening anal cancer prevention in Abuja, Nigeria: Identifying barriers and potential strategies to improve trainingConnor R Volpi, John Chama, Megan E Mansfield, et al.
Cell Death and Differentiation|February 18, 2026
RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTORRaúl E Flores-González, Christophe Goncalves, Noah Wirasinghe, et al.
BMC Cancer|November 14, 2025
Facilitator and barrier perspectives on learning and implementing high-resolution anoscopy in Abuja, Nigeria: a qualitative studyMegan E Mansfield, Connor R Volpi, Chama John, et al.
The Lancet. Infectious Diseases|April 24, 2026
Duration and association with protection of NANP-repeat-specific and C-terminus-specific anti-circumsporozoite protein IgG responses following RTS,S/AS01E vaccination: an observational ancillary immunological study of a phase 3 clinical trialMaria Lara-Escandell, Lina Sánchez, Dídac Macià, et al.
Journal of Clinical Virology Plus|January 23, 2023
Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in NigeriaNnaemeka C Iriemenam, Fehintola A Ige, Stacie M Greby, et al.
Pageof 19